ArticleCureus2026
Multi-chamber Intracardiac Extension and Embolic Stroke: A Rare Complication of Mediastinal Non-seminomatous Germ Cell Tumor.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary mediastinal non-seminomatous germ cell tumors (PMNSGCT) are aggressive malignancies. A rare and high-risk complication is the extension of the tumor into the cardiac chambers or the formation of tumor-associated thrombi, which carry a profound risk of systemic or pulmonary embolization. We present a complex case of a 21-year-old man with superior vena cava obstruction (SVCO) and massive, multi-chamber intracardiac tumor extension discovered incidentally following a presentation of chest pain and ST-segment elevation. He was found to have a pericardial effusion that later progressed to impending tamponade. Transesophageal echocardiography (TEE) revealed highly mobile masses within the right atrium (RA), right ventricle (RV), and left atrium (LA), the latter originating from the pulmonary veins. The clinical course was complicated by embolic cerebral infarcts. Despite the high risk of further embolization, the patient was managed with emergent pericardiocentesis, therapeutic anticoagulation, and VIP (Etoposide, Ifosfamide, Cisplatin) chemotherapy protocol. The patient achieved complete resolution of the intracardiac masses, demonstrating the efficacy of the "chemotherapy-first" medical debulking approach in managing high-risk inoperable intracardiac tumor burden. This case highlights the important role of echocardiography in intracardiac tumor diagnosis and the clinical challenge of distinguishing tumor thrombus from direct extension. It demonstrates the efficacy of a chemotherapy-first approach in managing high-risk or inoperable intracardiac tumor burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.